57th Annual Tuberculosis Course (Virtual Series): National Jewish Health

 

To: Health Care Providers and Lab Technicians From: National Jewish Health through the Colorado Department of Public Health and Environment   Join us for the most cutting-edge, comprehensive and longest running CME/CNE Tuberculosis Course in the United States. 57th Annual TB Course (Virtual Series) Fridays, April 2 - May 7, 2021 The TB Course will follow a new format in 2021, with weekly virtual presentations led by expert faculty from April 2 – May 7, 2021. After the virtual presentation each Friday, registered attendees will have access to the recorded sessions. Register Now! Topics and Speakers All sessions include Q&A and begin at 11 a.m. MST / 10 a.m. PST / 12 p.m. CST / 1 p.m. EST. Registrants who miss a live session can claim credit for viewing the recorded session when it is posted. Friday, April 2, 11:00 a.m. -12:15 p.m. (MST) Epidemiology: Randall Reves, MD Clinical Presentation and Imaging: Shannon Kasperbauer, MD Friday, April 9, 11:00 a.m. -12:15 p.m. (MST) Laboratory Services: Reeti Khare, PhD Diagnosis of LTBI: Robert Belknap, MD Friday, April 16, 11:00 a.m. -12:15 p.m. (MST) Treatment of Drug Susceptible TB: David Griffith, MD Treatment of Drug-Resistant TB: Charles Daley, MD ​Friday, April 23, 11:00 a.m. -12:15 p.m. (MST) Treatment of LTBI: Nicholas Walter, MD Monitoring and Management of Side Effects: Gwen Huitt, MD ​​Friday, April 30, 11:00 a.m. -12:15 p.m. (MST) TB and HIV Co-infection: Michelle Haas, MD Pediatric TB: James Gaensbauer, MD ​​Friday, May 7, 11:00 a.m. -12:00 p.m. (MST) Contact Investigation Workshop: Robert Belknap, MD Target Audience Public Health, Family, Internal Medicine, Infectious Disease and Preventive Medicine Physicians, Epidemiologists, Physician Assistants, Advanced Practice Nurses, Registered Nurses and other health care professionals interested in TB. Learning Objectives Discuss the epidemiological features which are associated with increased risk for tuberculosis. Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection. Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings. Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen. Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB. Register Cost: $225 General | $135 Military, Fellow and Resident (verification required) For more information and to register, please visit njhealth.org/TBCourse2021 or email: proed@njhealth.org. Accreditation and Designation Statements Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. National Jewish Health designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: Provider approved by the California Board of Registered Nursing, Provider Number CEP 12724, for 7.25 contact hours.